Overall volumes in futures & options currently stand at 59.59 lakh contracts with a turnover of Rs. 5,16,837.82 crore.

Overall volumes in futures & options currently stand at 59.59 lakh contracts with a turnover of Rs. 5,16,837.82 crore.

Going ahead, we expect the momentum to continue on the upside and Nifty may make an attempt to scale up to the levels of 10,580, followed by 10,640, whereas on the downside, supports are seen around the levels of 10,470 followed by 10,450. Stocks in the news: Bajaj Electricals, Adani Ports, Reliance Communication, Blue Star, Sobha, Sterlite Technologies, Omkar Speciality Chemicals, Goa Carbon and Fortis Healthcare.

Indian markets are likely to make a tepid start following subdued cues from Asian peers. The SGX Nifty is indicating that Nifty may open marginally lower at 10,539. 

Of the 13 IPOs that got listed on the exchanges in the calendar year 2018, only 5 are trading above their listing price.

The share price of automobile major Tata Motors declined on the bourses by over 4 per cent on Monday on the back of news reports suggesting that the company’s wholly-owned subsidiary Jaguar Land Rover would be laying-off a number of contractual employees.   

When the major indices were striving for fresh buying after the short covering at the end of last month, there were few stocks which can be called as defensives which continued upsurge even in cautious market conditions and hit their all-time high levels today.

Infosys opened with a gap-down of 6 per cent on Monday but its opening and low were the same and thereby it surged nearly 3 per cent on an intraday basis, attempting to cover the gap. Moreover, 1,098 acted as the 100-day EMA support for the stock.

BHEL will be performing the work of design, engineering, manufacture, supply, dismantling, erection, testing and commissioning of the ESPs to bring down the SPM emission within the stipulated levels.

Pharma major Cipla’s US subsidiary, InvaGen Pharmaceuticals Inc. recalled 11 lots of antidepressant bupropion hydrochloride ER tablets from the US markets on April 15.